AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including ...

Pascal Soriot, AstraZeneca’s chief executive, says the investment ‘reflects our belief in the world-class life sciences ecosystem in Beijing’ - Zach Gibson/Bloomberg AstraZeneca has unveiled ...

AstraZeneca has announced a $2.5bn investment to establish the company’s sixth worldwide strategic R&D centre in China.

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre together with major research and manufacturing agreements that will ...

March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned by the country's sound prospects as well as its growing innovation ...

British pharmaceutical giant AstraZeneca signed a landmark agreement earlier this month to invest $2.5 billion in Beijing over the next five years, demonstrating confidence in the capital's ...

AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators ...

AstraZeneca has shown its commitment to China amid investigations into its executives and activities, outlining plans to establish a global strategic R&D center in Beijing as part of a $2.5 ...

AstraZeneca inked a US$2.5 billion contract with the city government of Beijing to establish the firm’s sixth global strategic R&D centre, with high-end industrialisation projects conducted in ...

To support the collaboration and earlier initiatives between the companies, Harbour said it will establish an innovation center in Beijing, to be co-located with AstraZeneca’s planned $2.5 ...